Balaji Amines growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+2.0%−14.9%−30.3%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+14.3%−28.3%−46.9%
+13.8%−34.0%−50.6%
+6.7%−31.7%−42.7%
+6.1%−23.1%−37.1%
+21.8%+4.9%+9.3%
+6.6%+6.6%+11.5%
−28.0%+16.3%−42.5%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BALAMINES₹1,828.60

Balaji Amines Ltd.

· Chemicals
₹ CrorePeersALKYLAMINEDEEPAKNTRTECILCHEMAETHERACIELLENGHCLGNFCMcap ₹5,925 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—-30.3-14.9+2.0—
EBITDA Growth—-46.9-28.3+14.3—
EBIT Growth—-50.6-34.0+13.8—
Net Income Growth—-42.7-31.7+6.7—
EPS Growth—-37.1-23.1+6.1—
Total Assets Growth—+9.3+4.9+21.8—
Total Equity Growth—+11.5+6.6+6.6—
Cash from Operations Growth—-42.5+16.3-28.0—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.